TURP (transurethral resection of the prostate)

Occasionally, surgery is required to remove part of or the entire tumor around a man's uretha. The uretha is the tube that transports urine from the bladder.  An operation that takes away some of the cancer that is causing the symptoms may be suggested by the doctor, although this operation is not always performed to cure the cancer. It can, in fact just relieve the symptoms which are caused by the tumour pressing on the uretha. An example of such a symptom is the inability to empty the bladder properly. The most performed surgery is a TUR or TURP which stands for 'transurethral resection of the prostate.'

A TUR is performed by inserting a thin tube into the uretha via the penis. The tube contains a telescope allowing the surgeon to view inside the uretha. Any blockage is removed using an instrument which is attached to the telescope.  A patient is expected to spend two to three nights in hospital post surgery.

A TUR is usually performed under a general anaesthetic although some men have a spinal anaestetic, known as an epidural. This means that he remains awake but is unable to feel anything. An epidural may be suggested if the doctor believes that there are any reasons why the man should not have a general anaestetic, for example, unhealthy lungs or heart.

It is advised to begin moving around as much as possible following the operation and most men find that they are up and about within approximately 24 hours.

Many men have an intravenous infusion (drip) to replace the body fluids. This can be removed once normal drinking resumes as it is very important to drink plenty of fluids.  

Many patients have a catheter in situ which is a tube going into the bladder to drain urine into a bag. It is perfectly normal to find blood clots in the urine following this type of surgery and bladder irregation is often used to prevent any blood clots blocking the catheter. This involves the passing of fluid into the bladder which is then drained out of the catheter. You will note that the blood in the urine will clear slowly before the catheter can be removed, normally over two or three days post surgery. It is important to advise your doctor/nurse once you pass urine following the removal of the catheter.

Many men find that they are unable to pass urine once their catheter has been removed.  This is often due to swelling around the neck of the bladder and the prostate. You may have the catheter reinserted if you are unable to pass urine. Another attempt to urinate without the catheter will be made in a day or two.    

Some men have to keep their catheter in situ after they have gone home. Before discharge from hospital, the nurse will show the patient how to maintain the catheter and a district nurse will be arranged to help with any problems at home. If a patient belives he will experience difficulties coping at home, the nurse or a social worker should be notified so help can be arranged.

An appointment will be made to visit the out patient clinic for a check up approximately six weeks later. Problems you may be experiencing can also be discussed. 
Pain and discomfort will be experienced for a few days post surgery although there are a number of painkillling drugs available. This should be discussed with the doctor/nurse, especially if the pain continues.

Prostate cancer news on the Web


Prostate Cancer Awareness Month: Top Expert Debunks 4 Myths
MARLTON, N.J., Sept. 10 /PRNewswire/ -- September marks Prostate Cancer Awareness Month. For those diagnosed with the disease and their families, it's an ideal time to dispel common myths associated with prostate cancer. "Often the public's knowledge or understanding of the disease might not be accurate," says Michael Diefenbach, Ph.D., associate professor of Urology at Mount Sinai School of ...

Prostate cancer awareness group grateful for support
The Orillia Prostate Cancer Awareness Group wish to thank the cancer office, the Champlain Seniors, the volunteers and community groups that helped with the July 24 Tag Day. We thank the several sponsors and many businesses who allowed us to tag at their locations.[...]

Free prostate cancer screenings
Norwalk Hospital urologists will conduct a free prostate cancer screening in observance of “National Prostate Cancer Awareness Week.” The free screening, sponsored by the Whittingham Cancer Center of Norwalk Hospital, and coordinated by Linda Versea, administrative manager of the Whittingham Cancer Center, will be held Saturday, Sept. 18, from 9 to noon in the Cancer Center.

Heathcare Hotline: Understanding prostate cancer
Prostate cancer is the second leading cause of cancer death among American men. The American Cancer Society estimated that...

Prostate cancer treatments can vary
The prostate is a walnut-sized gland located just below the bladder in men.

Abiraterone Acetate For Metatastic Prostate Cancer So Effective That Phase 3 Trial Was Unblinded
Abiraterone Acetate plus prednisone was undergoing Phase 3 clinical trials on patients with metastatic advanced prostate cancer (castration-resistant prostate cancer) when an Independent Data Monitoring Committee recommended unblinding the study - this means the patients who were not receiving the Abiraterone Acetate should be offered it, Ortho Biotech Oncology Research & Development, a unit of ...

Palmetto Health offers free prostate cancer screenings
In observance of Prostate Cancer Awareness Month, Palmetto Health is offering free prostate cancer screenings throughout the community in September.

When To Test For Prostate Cancer?
Ads urge men of a certain age to get screened for prostate cancer. But is "test early, test often" the best approach? Otis Brawley of the American Cancer Society and Mark Scholz, author of Invasion Of The Prostate Snatchers, discuss other approaches.

Cancer Wellness at Piedmont Fayette Hospital Features Programs for Men
September is national Prostate Cancer Awareness Month and Cancer Wellness at Piedmont Fayette Hospital offers several programs specific to mens health issues. Although its mortality rate has steadily fallen in the last decade, prostate cancer is still the second leading cause of cancer death among men in the United States.At 12:30 p.m., Tuesday, September 14 and 28, Dennis Buttimer, M.Ed., RYT,...

J&J Prostate Cancer Drug Boosts Survival
J&J's abiraterone, if approved, will not be a direct competitor right away to Dendreon's prostate cancer vaccine.